Objectives: To examine the effect of reproductive history and use of hormonal therapies on the risk of hip and knee joint replacement for osteoarthritis.
Methods: Prospective study of 1.3 million women aged on average 56 years at recruitment and followed-up through linkage to routinely collected hospital admission records. The adjusted relative risk of hip and knee replacement for osteoarthritis was examined in relation to parity, age at menarche, menopausal status, age at menopause, and use of hormonal therapies.
Results: Over a mean of 6.1 person-years of follow-up 12,124 women had a hip replacement and 9,977 a knee replacement. The risk of joint replacement increased with increasing parity and the effect was greater for the knee than the hip: increase in relative risk of 2% (95%CI 1-4%) per birth for hip replacement and 8% (95%CI 6-10%) for knee replacement. An early age at menarche slightly increased the risk of both hip and knee replacement (relative risk for menarche ¡Ü11yrs versus 12yrs 1.09(95%CI 1.03-1.16) and 1.15(95%CI 1.08-1.22) respectively). Menopausal status and age at menopause were not clearly associated with risk. Current use of post-menopausal hormone therapy was associated with a significant increase in the incidence of both hip and knee replacement (RR=1.38(95%CI 1.30-1.46) and RR=1.58(95%CI 1.48-1.69) respectively) while previous use of oral contraceptives was not (RR=1.02(95%CI 0.98-1.06) and RR=1.00(95%CI 0.96-1.04) for hip and knee respectively).
Conclusions: Hormonal and reproductive factors affect the risk of hip and knee replacement, more so for the knee than the hip. The reasons for this are unclear.